INDAZOLE AND INDOLINE AS AROMATIC BIOISOSTERES IN THE IMIDAZOLE CLASS OF SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS

被引:7
作者
BERMUDEZ, J [1 ]
KING, FD [1 ]
SANGER, GJ [1 ]
机构
[1] SMITHKLINE BEECHAM PHARMACEUT,HARLOW CM19 5AD,ESSEX,ENGLAND
关键词
D O I
10.1016/S0960-894X(00)80418-7
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and 5-HT3 receptor antagonist activity of imidazole derivatives of 3-keto-indazoles, and 3,3-dimethylindolin-1-yl and o-methoxyphenyl amides is described. Results demonstrate that indazole and indoline are effective bioisosteres in the imidazole class of 5-HT3 receptor antagonists.
引用
收藏
页码:1509 / 1512
页数:4
相关论文
共 11 条
[1]  
AKABORI S, 1933, CHEM BER, V66, P156
[2]   THE ANTI-EMETIC POTENTIAL OF THE 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONIST BRL-43694 [J].
BERMUDEZ, J ;
BOYLE, EA ;
MINER, WD ;
SANGER, GJ .
BRITISH JOURNAL OF CANCER, 1988, 58 (05) :644-650
[3]   5-HYDROXYTRYPTAMINE (5-HT3) RECEPTOR ANTAGONISTS .3. ORTHO-SUBSTITUTED PHENYLUREAS [J].
BERMUDEZ, J ;
DABBS, S ;
KING, FD .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (07) :1932-1935
[4]   5-HYDROXYTRYPTAMINE (5-HT3) RECEPTOR ANTAGONISTS .1. INDAZOLE AND INDOLIZINE-3-CARBOXYLIC ACID-DERIVATIVES [J].
BERMUDEZ, J ;
FAKE, CS ;
JOINER, GF ;
JOINER, KA ;
KING, FD ;
MINER, WD ;
SANGER, GJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (07) :1924-1929
[5]   5-HYDROXYTRYPTAMINE (5-HT3) RECEPTOR ANTAGONISTS .2. 1-INDOLINECARBOXAMIDES [J].
BERMUDEZ, J ;
DABBS, S ;
JOINER, KA ;
KING, FD .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (07) :1929-1932
[6]   OLEFIN SYNTHESIS WITH ORGANIC PHOSPHONATE CARBANIONS [J].
BOUTAGY, J ;
THOMAS, R .
CHEMICAL REVIEWS, 1974, 74 (01) :87-99
[7]   PHARMACOLOGICAL PROPERTIES OF GR38032F, A NOVEL ANTAGONIST AT 5-HT3 RECEPTORS [J].
BUTLER, A ;
HILL, JM ;
IRELAND, SJ ;
JORDAN, CC ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 (02) :397-412
[8]  
KING FD, 1990, Patent No. 4946966
[9]   [H-3]-BRL-43694 (GRANISETRON), A SPECIFIC LIGAND FOR 5-HT3 BINDING-SITES IN RAT-BRAIN CORTICAL MEMBRANES [J].
NELSON, DR ;
THOMAS, DR .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (10) :1693-1695
[10]  
Oxford A W, 1992, Prog Med Chem, V29, P239, DOI 10.1016/S0079-6468(08)70010-9